Bayer Polymers to discontinue Cobalt-polybutadiene (CoBR) production in Marl
Reason for decision: drastic drop in demand for CoBR
Bayer Polymers, a division of Bayer AG, is planning to discontinue the production of Cobalt-polybutadiene (CoBR) at its subsidiary Bayer Buna GmbH in Marl in the first half of 2004. The reason for this decision is primarily the accelerating drop in demand for this rubber product. The CoBR facility has a total capacity of 45,000 metric tons. Some 75 employees will be affected. The company has started an information and consultation process with the works council and in the coming weeks will be working on finding individual solutions for those involved. Bayer Buna GmbH currently employs around 240 people in Marl. The production of EPDM rubber which also takes place in Marl is unaffected.
BR from Marl serves as a general-purpose rubber in tires and, in particular, as a plastics modifier for the manufacture of High Impact Polystyrene (HIPS), which is used in packaging materials and a variety of other applications. Owing to increasing substitution of CoBR by Lithium-polybutadiene (LiBR) in the HIPS application, production volumes have fallen drastically. "Closing the facility is therefore an absolute necessity in view of our strategy to improve profitability. Given the structural changes in the market, we see no possibility of continuing CoBR production in Marl," said Dr. Joachim Grub, Head of BR / Butyl Global Operations at Bayer Polymers.
Bayer Polymers will concentrate its remaining polybutadiene production at its sites in Orange (Texas, USA), Port Jérôme (France) and Dormagen (Germany).
Through a business acquisition in southern Germany, Bayer MaterialScience has expanded its position on the future-oriented market for composite materials. The company on Monday concluded the takeover of Thermoplast Composite GmbH (TCG) in Langenfeld, near Nuremberg, a technology leader spec ... more
The Supervisory Board of Bayer AG agreed to the proposal made by the Board of Management of Bayer AG to appoint Dr. Richard Pott (61) to the Supervisory Board of Bayer MaterialScience AG effective March 26, 2015. It is intended that Dr. Pott should be elected as the new Chairman of the Supe ... more
Bayer had a very successful year in 2014, both operationally and strategically. The company set new records for sales and for EBITDA before special items. “Contributing to this in particular was the continuing growth momentum in our Life Science businesses, and especially the pleasing devel ... more
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more
Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more